gefitinib has been researched along with Colonic Polyps in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bongers, G; Catalan-Dibene, J; Chen, G; Chen, L; Furtado, GC; He, Z; Lira, SA; Smaldini, P | 1 |
1 other study(ies) available for gefitinib and Colonic Polyps
Article | Year |
---|---|
Interleukin 1 beta and Matrix Metallopeptidase 3 Contribute to Development of Epidermal Growth Factor Receptor-Dependent Serrated Polyps in Mouse Cecum.
Topics: Animals; Apoptosis; Cecum; Colonic Polyps; Diphtheria Toxin; Disease Models, Animal; Epithelial Cells; ErbB Receptors; Fibroblasts; Gefitinib; Heparin-binding EGF-like Growth Factor; Humans; Hydroxamic Acids; Interleukin-1beta; Intestinal Mucosa; Matrix Metalloproteinase 3; Matrix Metalloproteinase Inhibitors; Mice; Mice, Transgenic; Receptor, Platelet-Derived Growth Factor alpha; Sulfonamides | 2019 |